Friday, May 24, 2019

Another reason to eat chocolate

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Related image
Loma Linda University Health

New studies show dark chocolate improves memory & mood, boosts immunity and reduces stress as well as inflammation. 


LOMA LINDA, CA — Findings from two studies show that consuming dark chocolate that has a high concentration of cacao (minimally 70% cacao, 30% organic cane sugar) has positive effects on:
  1. Stress levels
  2. Inflammation
  3. Mood
  4. Memory
  5. Immunity.

Effects of a Regular-Sized Chocolate Bar

“For years, we have looked at the influence of dark chocolate on neurological functions from the standpoint of sugar content - the more sugar, the happier we are," said Dr. Lee Berk. 

While it is well known that cacao is a major source of flavonoids, this is the first time the effect has been studied in human subjects to determine how it can support cognitive, endocrine and cardiovascular health. 

Lee S. Berk, DrPH, , served as principal investigator on both studies. Dr. Berk is associate dean of research affairs, School of Allied Health Professions and a researcher in psychoneuroimmunology and food science from Loma Linda University.

"Positive Impact"

Berk added, "This is the first time that we have looked at the impact of large amounts of cacao in doses as small as a regular-sized chocolate bar in humans over short or long periods of time, and are encouraged by the findings. These studies show us that the higher the concentration of cacao, the more positive the impact on cognition, memory, mood, immunity and other beneficial effects.” 

The flavonoids found in cacao are extremely potent antioxidants and anti-inflammatory agents, with known mechanisms beneficial for brain and cardiovascular health. The following resultswere presented in live poster sessions during the Experimental Biology 2018 meeting.

Two Studies on Dark Chocolate with 70% Cacao

These results were based on two important studies:
Berk said the studies require further investigation, specifically to determine the significance of these effects for immune cells and the brain in larger study populations. Further research is in progress to elaborate on the mechanisms that may be involved in the cause-and-effect brain-behavior relationship with cacao at this high concentration.

SOURCE:
  • Loma Linda University Health
    Loma Linda University Health includes Loma Linda University's eight professional schools, Loma Linda University Medical Center's six hospitals and more than 900 faculty physicians located in the Inland Empire of Southern California. Established in 1905, Loma Linda University Health is a global leader in education, research and clinical care. It offers over 100 academic programs and provides quality health care to over 40,000 inpatients and 1.5 million outpatients each year.

Wednesday, May 22, 2019

Reason why a dementia drug also is a blood pressure blood drug

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two



Georgetown University Medical Center

Top researchers show the generic drug candesartan (brand name: ATACAND®) may not only slow progression of Alzheimer’s, but also prevent or delay its development. See how. 




WASHINGTON  — In laboratory neuronal cultures, an FDA-approved drug used to treat high blood pressure reduced cell damage often linked to Alzheimer’s disease, say researchers at Georgetown University Medical Center (GUMC) and the National Institutes of Health.
They say their work, published online in the journal Alzheimer's Research and Therapy, provides information supporting the potential effect of the generic drug candesartan (brand name: ATACAND®) — as well as other Angiotensin receptor blockers (ARBs) for the early treatment of Alzheimer’s disease.
“Our findings make sense in many ways,” says the study’s senior author Juan M. Saavedra, MD, from GUMC’s Department of Pharmacology and Physiology.  “Hypertension reduces blood flow throughout the body and brain and is a risk factor of Alzheimer’s disease. Previous epidemiological studies found that Alzheimer’s progression is delayed in hypertensive patients treated with ARBs.”
Using neuronal cultures, the researchers explored the action of candesartan on the neurotoxic effects of exposure to excessive glutamate, a demonstrated injury factor in the early stages of Alzheimer’s disease.
The scientists found that candesartan prevented glutamate-induced neuronal death. They conducted in-depth gene analyses of the laboratory results, demonstrating that candesartan prevented neuronal inflammation and many other pathological processes, including alterations in amyloid metabolism, a hallmark of Alzheimer’s disease.
The study’s first author, Abdel G. Elkahloun, PhD, from the Comparative Genomics and Cancer Genetics Branch of the National Human Genome Research Institute, then compared gene expression in the neuronal cultures with published gene databases of autopsy samples from Alzheimer’s disease patients. “The correlations were impressive — the expression of 471 genes that were altered by excess glutamate in our cultures were also altered in brain autopsy samples from patients who suffered from Alzheimer’s disease. Candesartan normalized expression of these genes in our cultures,” Elkahloun says.
“We hypothesize that candesartan, or other members of the ARB group, may not only slow progression of Alzheimer’s but also prevent or delay its development,” Saavedra says.
The researchers say this work has immediate translational value, supporting testing candesartan, or other ARBs, in controlled clinical studies on patients at early stages of Alzheimer’s disease. 
MORE INFORMATION:Roman Hafko, PhD, formerly of the National Institute of Mental Health, also contributed to this work and is an author of the paper.
The work was supported by grants from the National Institutes of Health including the National Human Genome Research Institute (MD 20892) and the National Institute of Mental Health (MH 002762-16). The authors report having no personal financial interests related to the study.
SOURCE:
Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization (BGRO), which accounts for the majority of externally funded research at GUMC including a Clinical Translation and Science Award from the National Institutes of Health. 

Friday, May 17, 2019

Does sleeping on your back cause memory loss?

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Older man, who can’t sleep at night, sitting on bed while spouse sleeps



Could sleeping on your back hurt memory and increase your brain's risk of developing neurodegenerative disease? 




CARLSBAD, Calif.--(BUSINESS WIRE)--Could sleeping on your back increase your brain's risk of developing neurodegenerative disease? That possibility is revealed in a new study published in the Journal of Alzheimer's Disease. 

"We compared the in-home sleep patterns of patients with memory impairment resulting from neurodegenerative diseases to a large group of elderly with normal cognition," stated Daniel J. Levendowski, the study's first author and President of Advanced Brain Monitoring. "Sleeping more than 2 hours with one's head lying face upward (i.e., supine) was a significant nocturnal marker that characterized those with memory impairment, after controlling for factors such as age, sex, snoring, obstructive sleep apnea, and movements during the night."

Supine Sleep + Natural Aging

These results corroborate in humans a finding observed in rats by researchers at Stony Brook University and published in the Journal of Neuroscience. Using dynamic contrast MRI, they found that the clearance of neurotoxic proteins from the brain by glymphatic transport was less efficient when the rats' heads were in the supine sleep position. "Our results clearly support their conclusions," added Dr. Philip Westbrook, Chief Medical Officer of Advanced Brain Monitoring. "We also suggest how the interaction between supine sleep and the natural changes that come with age could impact the clearance of β-amyloid, tau, alpha-synuclein, and other neurotoxins from the brain during sleep."

Strong Association, Potentially Modifiable

Because imaging of the lymphatic system in humans is not yet possible, additional research is needed to establish a causal relationship between neurodegenerative disease and supine sleep.
"The strength of the association, however, points to a potentially modifiable risk factor for neurodegenerative disease, similar to diet and exercise,"
suggested Dr. Charlene Gamaldo, a co-author and Associate Professor of Neurology at Johns Hopkins University School of Medicine. 

The study results were obtained as part of a $2.5 million multi-site longitudinal study funded by the National Institute of Aging and awarded to Advanced Brain Monitoring. The aim of this ongoing research is to characterize the brain's function during wake and sleep to provide early identification and differentiation between mild cognitive impairment, Alzheimer's, Parkinson’s, and other dementias. 

"This is one of many neurodegenerative disease markers we've identified to predict the likelihood of a dementia subtype, quantifying the progression of the disease, and evaluating efficacy of new treatments,” said Chris Berka, principal investigator for the project and CEO of Advanced Brain Monitoring. 


REFERENCE:
SOURCE:
  • Advanced Brain Monitoring, Inc. is a privately-held neuro-diagnostics device company, specializing in the acquisition and analysis of EEG during wake and sleep. The Company's products are used in clinical trials and in clinical practice to interpret brain function as it relates to early stage neurodegeneration and chronic diseases, and to improve sleep quality and enhance performance. Since 2013, the Company has been awarded 15 patents, which includes seven FDA-cleared and CE-marked products. From its inception in 1999, the Company has been awarded over $35 million in government R&D funding.

Wednesday, May 1, 2019

How to keep those with dementia physically active

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two



Sit and Be Fit - Season Eight

SOURCE:
National Institute on Aging
National Institutes of Health
U.S. Department of Health & Human Services
Go4Life is a registered trademark of the U.S. Department of Health and Human Services.

ACTIVITIES FOR ANY DAY - 6 HEALTHY TIPS to help you stay active with Alzheimer's, along with physical activities to do. 



Caregivers can help people with dementia be more active and stay safe:

  1. Be realistic about how much activity can be done at one time. Several 10-minute "mini-workouts" may be best.
  2. Help get the activity started or join in to make the activity more fun.
  3. Find time in the morning for exercise.
  4. Break exercises into simple, easy-to-follow steps.
  5. Choose comfortable clothes that are suitable for the weather and appropriate shoes that fit well.
  6. Make sure both you and the person with dementia drink plenty of water when exercising.

Some physical activities to try:

  • Take a walk together.
  • Do simple tasks around the house, such as sweeping and raking.
  • Work in the garden.
  • Play music and dance.
  • Exercise with videos made for older people. Try the sample workout on NIA's free Go4Life DVD.
  • Throw a soft rubber exercise ball back and forth.
  • Lift weights or household items such as soup cans.
  • Use resistance bands, which you can buy in sporting goods stores. Be sure to follow the instructions.

Quick Tip

Try being active together. Physical activity and exercise are good for caregivers, too!

Visit:

www.nia.nih.gov/Go4Life
  • Read more tips for adding physical activity to your day.
  • Print useful tools.
  • Order a free exercise DVD.
  • Share your exercise story.
Go4Life: 
Everyday Fitness Ideas from the National Institute on Aging at NIH
Helping People with Dementia Disease Stay Physically Active




SOURCE:
National Institute on Aging
National Institutes of Health
U.S. Department of Health & Human Services
Go4Life is a registered trademark of the U.S. Department of Health and Human Services.

Sunday, April 28, 2019

Do these things cause dementia?

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Which of these cause Alzheimer's: 
1) Flu shots?
2) Aluminum?
3) Statin drugs?
See the latest research. 



Video on Aluminum and Flu Shots

Statins

Researchers question whether there is substance to the US Food and Drug Agency's recent warning that statins could affect the memory, attention span and other cognitive abilities of people who take this drug to control high cholesterol. This follows a systematic review of 25 clinical trials incorporating nearly 47,000 people. It was led by Brian R. Ott, M.D., director of The Alzheimer's Disease & Memory Disorders Center at Rhode Island Hospital and professor at the Alpert Medical School of Brown University in the U.S. The review findings¹ appear in the Journal of General Internal Medicine², published by Springer. 

Since 2012, the FDA regulates that labels on statin packaging should warn that the drugs could change users' cognitive abilities. These cognitive changes could include attention span, problem solving, memory, and language or visuospatial abilities. The warning was based on surveillance and case reports, observational studies and randomized trials.

Subsequent reviews of available research have cast doubts on the cautionary stance taken by the FDA. Ott's team therefore set out to do a more comprehensive analysis using well-studied analysis methods. They scrutinized the data of 25 relevant randomized clinical trials that investigated a possible link between statin therapy and mental ability. Combined, these studies included the test results of 46,836 patients. Ott and his colleagues also contrasted and combined the results of 14 of these studies through a meta-analysis, which in total included 27,643 participants.

The review found no significant effect of statin use on the mental capacity of either people with normal brain functioning or even those with Alzheimers' disease. The results suggest that the FDA's statin warning should be re-evaluated. Ott also believes there is a need to investigate the reasons behind the differences in the review results and the initial reports on which the FDA warning was based. It could be that some of the mental changes that were reported in the case studies were the result of overdosing with statins.

The review findings are congruent with the 2013 safety statement made by the American College of Cardiology and the American Heart Association Cholesterol Guideline. It advises that patients on statins who seem to be confused or who might have memory problems should be evaluated for causes other than their cholesterol medication. This could include the use of other drugs or systemic and neuro-psychiatric causes.

The researchers believe that there is more benefit to be had by sticking to statin therapy to manage heart-related diseases and prevent strokes than worrying about the possible adverse mental effects of these drugs.

"We found no significant effects of statin treatment on cognition," concludes Ott. "Given these results, it is questionable whether the FDA class warning about potential cognitive adverse effects of statins is still warranted.."

Wednesday, April 24, 2019

How to pick the right gift for those with dementia for Mother's Day

Activities directors and other healthcare professionals here is a great dementia resource for caregivers and healthcare professionals.

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Image result for adorable photos for those with dementia

Choosing the right present for someone with Alzheimer's disease or a related dementia is certain to give him/her joyful times independently or with a loved one. Here are some tips on how to pick a perfect gift. You can give a gift anytime, but Mother's Day is coming soon which is a perfect opportunity to give that special someone a special gift.


Over 5.4 million Americans are living with dementia. Is one of them someone you know or a client of yours? Get him/her or anyone with Alzheimer's disease or another dementia, a gift that will keep on giving
Of course, person appropriate offerings are the best. This means matching a gift to a person's interests and abilities, However, there are some presents that will make them smile no matter what.

One such gift is a book by Susan Berg called Adorable Photographs of Our Baby -- Meaningful, Mind-Stimulating Activities and More for the Memory Challenged, Their Loved Ones and Involved Professionals, This book features baby photographs that seniors with dementia love. This book shares a plethora of ideas and resources for you. Mothers especially love babies

Another gift dementia persons will fancy is a classic musical video or DVD especially a musical love story. A classic movie of this type is Rogers and Hammerstein's movie, Carousel (1945) or South Pacific (1949)


click here for the whole story

Sunday, April 21, 2019

Is there a relation between Alzheimer's and sleep?

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two




The link between sleep, beta-amyloid and Alzheimer's is increasingly clear. Beta-amyloid deposition leads to a vicious cycle - it disturbs sleep and impairs memory, which trigger further deposition. Learn what it means for lowering Alzheimer's risk and improving sleep habits. 




Scientists at the University of California, Berkeley, have found compelling evidence that poor sleep -- particularly a deficit of the deep, restorative slumber needed to hit the save button on memories -- is a channel through which the beta-amyloid protein believed to trigger Alzheimer's disease attacks the brain's long-term memory. (Beta-amyloid is the protein that makes up the toxic plaque that is the most common suspect behind Alzheimer's.)

"Our findings reveal a new pathway through which Alzheimer's disease may cause memory decline later in life," said UC Berkeley neuroscience professor Matthew Walker, senior author of the study to be published in the journalNature Neuroscience.

Excessive deposits of beta-amyloid are key suspects in the pathology of Alzheimer's disease, a virulent form of dementia caused by the gradual death of brain cells. An unprecedented wave of aging baby boomers is expected to make Alzheimer's disease, which has been diagnosed in more than 40 million people, one of the world's fastest-growing and most debilitating public health concerns.

The Good News

The good news about the findings, Walker said, is that poor sleep is potentially treatable and can be enhanced through exercise, behavioral therapy and even electrical stimulation that amplifies brain waves during sleep, a technology that has been used successfully in young adults to increase their overnight memory.

"This discovery offers hope," he said. "Sleep could be a novel therapeutic target for fighting back against memory impairment in older adults and even those with dementia."

The study was co-led by UC Berkeley neuroscientists Bryce Mander and William Jagust, a leading expert on Alzheimer's disease. The team has received a major National Institutes of Health grant to conduct a longitudinal study to test their hypothesis that sleep is an early warning sign or biomarker of Alzheimer's disease.

Real People

While most research in this area has depended on animal subjects, this latest study has the advantage of human subjects recruited by Jagust, a professor with joint appointments at UC Berkeley's Helen Wills Neuroscience Institute, the School of Public Health and the Lawrence Berkeley National Laboratory.

"Over the past few years, the links between sleep, beta-amyloid, memory, and Alzheimer's disease have been growing stronger," Jagust said. "Our study shows that this beta-amyloid deposition may lead to a vicious cycle in which sleep is further disturbed and memory impaired."

Using a powerful combination of brain imaging and other diagnostic tools on 26 older adults who have not been diagnosed with dementia, researchers looked for the link between bad sleep, poor memory and the toxic accumulation of beta-amyloid proteins.

"The data we've collected are very suggestive that there's a causal link," said Mander, lead author of the study and a postdoctoral researcher in the Sleep and Neuroimaging Laboratory directed by Walker. "If we intervene to improve sleep, perhaps we can break that causal chain."

A buildup of beta-amyloid has been found in Alzheimer's patients and, independently, in people reporting sleep disorders. Moreover, a 2013 University of Rochester study found that the brain cells of mice would shrink during non-rapid-eye-movement (non-REM) sleep to make space for cerebrospinal fluids to wash out toxic metabolites such as beta-amyloid.

How It Works

"Sleep is helping wash away toxic proteins at night, preventing them from building up and from potentially destroying brain cells," Walker said. "It's providing a power cleanse for the brain."

Specifically, the researchers looked at how the quantity of beta-amyloid in the brain's medial frontal lobe impairs deep non-REM sleep, which we need to retain and consolidate fact-based memories.

In a previous study, Mander, Jagust and Walker found that the powerful brain waves generated during non-REM sleep play a key role in transferring memories from the hippocampus -- which supports short-term storage for information -- to longer-term storage in the frontal cortex. In elderly people, deterioration of this frontal region of the brain has been linked to poor-quality sleep.

For this latest study, researchers used positron emission tomography (PET) scans to measure the accumulation of beta-amyloid in the brain; functional Magnetic Resonance Imaging (fMRI) to measure activity in the brain during memory tasks; an electroencephalographic (EEG) machine to measure brain waves during sleep; and statistical models to analyze all the data.

The research was performed on 26 older adults, between the ages of 65 and 81, who showed no existing evidence of dementia or other neurodegenerative, sleep or psychiatric disorders. First, they each received PET scans to measure levels of beta-amyloid in the brain, after which they were tasked with memorizing 120 word pairs, and then tested on how well they remembered a portion of them.

The study participants then slept for eight hours, during which EEG measured their brain waves. The following morning, their brains were scanned using fMRI as they recalled the remaining word pairs. At this point, researchers tracked activity in the hippocampus, where memories are temporarily stored before they are transferred to the prefrontal cortex.

Memory & Sleep

"The more you remember following a good night of sleep, the less you depend on the hippocampus and the more you use the cortex," Walker said. "It's the equivalent of retrieving files from the safe storage site of your computer's hard drive, rather than the temporary storage of a USB stick."

Overall, the results showed that the study participants with the highest levels of beta-amyloid in the medial frontal cortex had the poorest quality of sleep and, consequently, performed worst on the memory test the following morning, with some forgetting more than half of the information they had memorized the previous day.

"The more beta-amyloid you have in certain parts of your brain, the less deep sleep you get and, consequently, the worse your memory," Walker said. "Additionally, the less deep sleep you have, the less effective you are at clearing out this bad protein. It's a vicious cycle.

"But we don't yet know which of these two factors -- the bad sleep or the bad protein -- initially begins this cycle. Which one is the finger that flicks the first domino, triggering the cascade?" Walker added.

And that's what the researchers will determine as they track a new set of older adults over the next five years. 
"This is a new pathway linking Alzheimer's disease to memory loss, and it's an important one because we can do something about it," Mander said.




Source:


Journal Reference:

  1. Matthew P Walker et al. β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nature Neuroscience, June 2015 DOI: 10.1038/nn.4035
Blog Flux Directory
alzheimersideas - whereIstand.com

Fitness is important in dementia prevention. Click below for more info